HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations.

AuthorsD Dvorakova, M Lengerova, J Pospisilova, I Palasek, J Mayer
JournalLeukemia (Leukemia) Vol. 23 Issue 4 Pg. 793-6 (Apr 2009) ISSN: 1476-5551 [Electronic] England
PMID18830256 (Publication Type: Evaluation Study, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin
Topics
  • Exons
  • Humans
  • Leukemia, Myeloid, Acute (diagnosis, genetics)
  • Methods
  • Mutation
  • Neoplasm, Residual (diagnosis, genetics)
  • Nuclear Proteins (genetics)
  • Nucleophosmin
  • Polymerase Chain Reaction (methods, standards)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: